Hypoglycemia Pipeline 2016 H1 Market Research and Review Report

Mar 31, 2016, 02:00 ET from RnR Market Research

PUNE, India, March 31, 2016 /PRNewswire/ --

RnRMarketResearch.com adds "Hypoglycemia - Pipeline Review, H1 2016" market research report with comprehensive information on the therapeutic development for Hypoglycemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypoglycemia and special features on late-stage and discontinued projects.

Complete report on H1 2016 pipeline review of Hypoglycemia with 27 market data tables and 13 figures, spread across 75 pages is available at http://www.rnrmarketresearch.com/hypoglycemia-pipeline-review-h1-2016-market-report.html   

The report also reviews key players involved in the therapeutic development for Hypoglycemia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this Hypoglycemia Pipeline Review, H1 2016 report include Biodel Inc., Eiger BioPharmaceuticals, Inc., Eli Lilly and Company, Heptares Therapeutics Limited, Novartis AG, Sanofi, SkyePharma Plc, Therakind Limited, USV Limited, XERIS Pharmaceuticals, Inc., XOMA Corporation and Zealand Pharma A/S. Drug profiles discussed in this research report includes AMG-5041, Biologic for Hypoglycemia, Drug for Hypoglycemia, exendin-(9-39), glucagon, LY-3143753, LY-3185643, pasireotide, SAR-438544, Small Molecule to Antagonize GLP-1 Receptor Hypoglycemia, terbutaline sulphate MR, XOMA-129, XOMA-358 and ZP-4207.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=516303  

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Hypoglycemia and reviews pipeline therapeutics for Hypoglycemia by companies and universities/research institutes based on information derived from company and industry-specific sources and key players involved Hypoglycemia therapeutics and enlists all their major and minor projects. The research covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities and assesses Hypoglycemia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects with latest news related to pipeline therapeutics for Hypoglycemia.

Another newly published market research report titled on Insulin Resistance - Pipeline Review, H1 2016 provides comprehensive information on the therapeutic development for Insulin Resistance, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Insulin Resistance and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Insulin Resistance Pipeline market research report of 62 pages is available at http://www.rnrmarketresearch.com/insulin-resistance-pipeline-review-h1-2016-market-report.html   

Explore more reports on Diabetes Therapeutics .

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research